Company Filing History:
Years Active: 1997-1999
Title: Innovations of Larry R. Solomon in Hepatitis B Research
Introduction
Larry R. Solomon is a notable inventor based in Mundelein, IL (US). He has made significant contributions to the field of medical research, particularly in the area of Hepatitis B virus detection and treatment. With a total of four patents to his name, Solomon's work has had a profound impact on diagnostic and therapeutic applications.
Latest Patents
Among his latest patents, Solomon has developed mutant Hepatitis B Virus (HBV) nucleic acid sequences that are useful for a variety of diagnostic and therapeutic applications. These patents include kits for utilizing the HBV nucleic acid sequences, HBV immunogenic particles, and methods for producing antibodies to HBV. Additionally, he has provided methods for producing both polyclonal and monoclonal antibodies from the HBV nucleic acid sequences.
Career Highlights
Larry R. Solomon is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions for Hepatitis B, contributing to advancements in medical diagnostics and treatments.
Collaborations
Throughout his career, Solomon has collaborated with esteemed colleagues such as William Frederick Carman and Richard H. Decker. These collaborations have further enhanced the research and development of effective methods for detecting and treating Hepatitis B.
Conclusion
Larry R. Solomon's contributions to Hepatitis B research through his patents and collaborations have established him as a key figure in the field. His innovative work continues to influence diagnostic and therapeutic practices in medicine.